| abstract |
The disclosure relates to glucopyranosyl-substitutedted benzol derivatives of general formula (I), wherein the variables R1 to R6 and R7a, R7b, R7c are such as defined in the specification, including the tautomers, stereoisomers, mixtures and the salts thereof. These compounds are useful for treating metabolic diseases, for the treatment or prevention of diseases or conditions which can be influenced by inhibiting the sodium-dependent glucose co-transporter SGLT, for preventing the degeneration of pancreatic beta cells and/or for improving and/or restoring the functionality of pancreatic beta cells, and for preparing diuretics and/or antihypertensives. |